The House and Senate are finishing up a continuing resolution (CR) that will fund the federal government through December 3, and plan to adjourn after voting on the CR until November. Under the CR, funding will continue at FY 2010 enacted levels for most programs – including cancer research programs at the National Institutes of Health and colorectal cancer control programs at the Centers for Disease Control and Prevention. Congress is not expected to finish the fiscal year 2011 appropriations bills until after the election.
Take action today, and tell Congress to increase fiscal year 2011 cancer research funding. As they head home for the election, take a minute to remind Members that they have work to finish when they come back to DC in November. Tell your Senators and Representative that you expect them to make colorectal cancer a top priority.
The Colorectal Cancer Coalition is working with Congressional leaders to increase fiscal year 2011 funding for the following colorectal cancer research and control programs:
- $50 million in funding for the Peer Reviewed Cancer Research Program (PRCRP) at the Department of Defense
- $35.2 billion for the National Institutes of Health (NIH)
- $5.79 billion for National Cancer Institute (NCI)
- $240 million for the National Center on Minority Health and Health Disparities (NCMHD)
- $601 million for Centers for Disease Control and Prevention (CDC) cancer programs
- $50 million for CDC’s National Comprehensive Cancer Control Program
- $50 million for CDC’s Colorectal Cancer Screening, Education & Outreach Initiative
- $65 million for CDC’s National Program of Cancer Registries
- $2.857 billion for the Food and Drug Administration (FDA)
Thanks to research, we have made great strides in the fight against colorectal cancer and treatment options have expanded to seven drugs. Today, people diagnosed with metastatic colorectal cancer are living longer than ever. But there is more work to be done, and we need continued federal funding of research programs to win the fight against colorectal cancer.